Floatz logo

Bbm-D101

DMD

Belief BioMed (Beijing) Co., LtdPhase 1/2Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the DMD cohort.

Asset / SponsorPhaseRating
Aoc 1044
Avidity Biosciences, Inc.
Phase 3BB
Zeleciment Rostudirsen
Dyne Therapeutics
Phase 3B

Same molecule, other indications

Bbm-D101 is also rated in:

Duchenne muscular dystrophyDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →